ASSURANT, INC.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), ASSURANT, INC. reported revenue of $12.8B (+7.9% year on year) and net income of $872.7M (+14.8% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net earned premiums | $10.5B | $9.8B | $9.4B | $8.8B |
| Fees and other income | $1.9B | $1.6B | $1.3B | $1.2B |
| Net investment income | $527.3M | $518.9M | $489.1M | $364.1M |
| Net realized losses on investments (including $6.7, $25.1 and $17.0 of impairment-related losses for the years ended December 31, 2025, 2024 and 2023, respectively) and fair value changes to equity securities | ($71.8M) | ($75.8M) | ($68.7M) | ($179.7M) |
| Total revenues | $12.8B | $11.9B | $11.1B | $10.2B |
| Policyholder benefits | $2.9B | $2.8B | $2.5B | $2.4B |
| Underwriting, selling, general and administrative expenses | $8.7B | $8.1B | $7.7B | $7.4B |
| Interest expense | $109.7M | $107.0M | $108.0M | $108.3M |
| Loss (gain) on extinguishment of debt (Note 18) | $1.3M | $0 | ($100.0K) | $900.0K |
| Total benefits, losses and expenses | $11.7B | $11.0B | $10.3B | $9.8B |
| Income before income tax expense | $1.1B | $927.3M | $806.8M | $349.9M |
| Income tax expense | $214.7M | $167.1M | $164.3M | $73.3M |
| Net income | $872.7M | $760.2M | $642.5M | $276.6M |
| Basic (in dollars per share) | $17.14 | $14.55 | $12.02 | $5.09 |
| Diluted (in dollars per share) | $16.93 | $14.46 | $11.95 | $5.05 |
| Weighted average common shares outstanding used in basic per common share calculations (in shares) | 50.5M | 52.2M | 53.5M | 54.4M |
| Plus: Dilutive securities (in shares) | 617.0K | 349.4K | 327.9K | 411.0K |
| Weighted average common shares used in diluted per common share calculations (in shares) | 51.1M | 52.6M | 53.8M | 54.8M |
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 | Jun 30, 2025 · Q2 |
|---|---|---|---|---|
| Net earned premiums | $2.8B | $2.8B | $2.6B | $2.6B |
| Fees and other income | $554.6M | $499.8M | $484.4M | $463.7M |
| Net investment income | $142.4M | $159.6M | $133.5M | $128.7M |
| Net realized losses on investments (including $2.4, $0.0, $(3.2) and $(3.0) of impairment-related gains (losses) for the three and six months ended June 30, 2026 and 2025, respectively) and fair value changes to equity securities | ($10.2M) | ($21.2M) | ($13.6M) | ($21.7M) |
| Total revenues | $3.5B | $3.4B | $3.2B | $3.2B |
| Policyholder benefits | $748.3M | $769.1M | $709.6M | $721.5M |
| Underwriting, selling, general and administrative expenses | $2.3B | $2.3B | $2.2B | $2.1B |
| Interest expense | $28.4M | $28.3M | $27.9M | $26.7M |
| Total benefits, losses and expenses | $3.1B | $3.1B | $2.9B | $2.9B |
| Income before income tax expense | $376.9M | $335.6M | $331.2M | $289.0M |
| Income tax expense | $78.3M | $61.5M | $65.6M | $53.7M |
| Net income | $298.6M | $274.1M | $265.6M | $235.3M |
| Basic (in dollars per share) | $5.98 | $5.47 | $5.22 | $4.60 |
| Diluted (in dollars per share) | $5.95 | $5.41 | $5.17 | $4.56 |
| Weighted average common shares outstanding used in basic per common share calculations (in shares) | 49.5M | 49.7M | 50.8M | 51.1M |
| Plus: Dilutive securities (in shares) | 310.7K | 495.0K | 488.8K | 436.5K |
| Weighted average common shares outstanding used in diluted per common share calculations (in shares) | 49.8M | 50.2M | 51.3M | 51.6M |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Fixed maturity securities available for sale, at fair value (net of allowances for credit losses of $1.9 and zero at December 31, 2025 and 2024, respectively; amortized cost – $8,635.3 and $7,524.8 at December 31, 2025 and 2024, respectively) | $8.6B | $7.2B | $6.9B | $6.3B |
| Equity securities at fair value | $207.1M | $208.5M | $223.0M | $281.3M |
| Commercial mortgage loans on real estate, at amortized cost (net of allowances for credit losses of $6.7 and $6.5 at December 31, 2025 and 2024, respectively) | $324.7M | $342.5M | $328.7M | $295.6M |
| Short-term investments | $379.5M | $281.6M | $258.1M | $155.5M |
| Other investments | $573.0M | $536.8M | $499.0M | $508.4M |
| Total investments | $10.1B | $8.5B | $8.2B | $7.5B |
| Cash and cash equivalents | $1.8B | $1.8B | $1.6B | $1.5B |
| Premiums and accounts receivable (net of allowances for credit losses of $10.4 and $7.2 at December 31, 2025 and 2024, respectively) | $2.0B | $2.1B | $2.3B | $2.4B |
| Reinsurance recoverables (net of allowances for credit losses of $5.2 and $5.0 at December 31, 2025 and 2024, respectively) | $6.5B | $7.6B | $6.6B | $7.0B |
| Accrued investment income | $135.4M | $130.5M | $97.0M | $85.1M |
| Deferred acquisition costs | $10.2B | $10.0B | $10.0B | $9.7B |
| Property and equipment, net | $841.7M | $768.3M | $685.8M | $645.1M |
| Goodwill | $2.6B | $2.6B | $2.6B | $2.6B |
| Other intangible assets, net | $522.0M | $535.6M | $567.1M | $638.9M |
| Other assets (net of allowances for credit losses of $0.9 and $0.6 at December 31, 2025 and 2024, respectively) | $1.1B | $983.7M | $862.3M | $738.3M |
| Assets held for sale (Note 3) | $512.4M | — | — | $0 |
| Total assets | $36.3B | $35.0B | $33.6B | $33.1B |
| Future policy benefits and expenses | $55.7M | $536.7M | $487.2M | $428.5M |
| Unearned premiums | $20.9B | $20.2B | $20.1B | $19.8B |
| Claims and benefits payable | $2.1B | $2.9B | $2.0B | $2.3B |
| Commissions payable | $640.6M | $559.6M | $542.8M | $647.5M |
| Funds held under reinsurance | $266.4M | $277.7M | $392.7M | $366.6M |
| Accounts payable and other liabilities (including allowances for credit losses of $0.9 and $1.4 at December 31, 2025 and 2024) | $3.8B | $2.8B | $2.8B | $2.7B |
| Debt | $2.2B | $2.1B | $2.1B | $2.1B |
| Liabilities held for sale (Note 3) | $499.5M | — | — | $0 |
| Total liabilities | $30.4B | $29.9B | $28.8B | $28.9B |
| Common stock, par value $0.01 per share, 800,000,000 shares authorized, 52,089,008 and 53,129,838 shares issued and 49,792,919 and 50,833,749 shares outstanding at December 31, 2025 and 2024, respectively | $500000.00 | $500000.00 | $600000.00 | $600000.00 |
| Additional paid-in capital | $1.7B | $1.7B | $1.7B | $1.6B |
| Retained earnings | $4.8B | $4.4B | $4.0B | $3.7B |
| Accumulated other comprehensive loss | ($544.2M) | ($836.1M) | ($765.0M) | ($986.2M) |
| Treasury stock, at cost; 2,296,089 shares at December 31, 2025 and 2024 | -122.8M | -122.8M | -122.8M | — |
| Total equity | $5.9B | $5.1B | $4.8B | $4.2B |
| Total liabilities and equity | $36.3B | $35.0B | $33.6B | $33.1B |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Fixed maturity securities available for sale, at fair value (net of allowances for credit losses of $— and $1.9 at June 30, 2026 and December 31, 2025, respectively; amortized cost - $9,133.1 and $8,635.3 at June 30, 2026 and December 31, 2025, respectively) | $9.0B | $8.8B | $8.3B | $8.1B |
| Equity securities at fair value | $195.7M | $197.3M | $214.0M | $207.9M |
| Commercial mortgage loans on real estate, at amortized cost (net of allowances for credit losses of $6.3 and $6.7 at June 30, 2026 and December 31, 2025, respectively) | $305.4M | $309.5M | $328.2M | $329.8M |
| Short-term investments | $335.2M | $329.8M | $345.8M | $316.3M |
| Other investments | $631.7M | $601.5M | $596.8M | $592.1M |
| Total investments | $10.5B | $10.2B | $9.8B | $9.5B |
| Cash and cash equivalents | $1.7B | $1.6B | $1.7B | $1.5B |
| Premiums and accounts receivable (net of allowances for credit losses of $16.8 and $10.4 at June 30, 2026 and December 31, 2025, respectively) | $2.0B | $2.0B | $1.9B | $1.9B |
| Reinsurance recoverables (net of allowances for credit losses of $5.2 at June 30, 2026 and December 31, 2025) | $6.4B | $6.5B | $7.1B | $7.3B |
| Accrued investment income | $133.1M | $118.7M | $120.7M | $123.8M |
| Deferred acquisition costs | $10.4B | $10.2B | $10.1B | $10.1B |
| Property and equipment, net | $849.6M | $848.9M | $831.1M | $811.5M |
| Goodwill | $2.7B | $2.7B | $2.6B | $2.6B |
| Other intangible assets, net | $487.7M | $511.1M | $527.5M | $529.9M |
| Other assets (net of allowances for credit losses of $0.9 at June 30, 2026 and December 31, 2025) | $1.1B | $1.1B | $1.1B | $1.0B |
| Assets held for sale (Note 4) | $0 | $0 | — | — |
| Total assets | $36.1B | $35.8B | $35.8B | $35.5B |
| Future policy benefits and expenses | $53.8M | $54.7M | $510.1M | $511.7M |
| Unearned premiums | $21.1B | $20.9B | $20.6B | $20.5B |
| Liability for Claims and Claims Adjustment Expense | $2.1B | $2.2B | $2.2B | $2.4B |
| Commissions payable | $623.3M | $606.0M | $594.2M | $597.3M |
| Funds held under reinsurance | $282.0M | $287.1M | $279.4M | $268.1M |
| Accounts payable and other liabilities (including allowances for credit losses of $0.6 and $0.9 at June 30, 2026 and December 31, 2025, respectively, for the unsecured portion of the high deductible recoverables) | $3.6B | $3.7B | $3.6B | $3.7B |
| Debt | $2.2B | $2.2B | $2.2B | $2.1B |
| Liabilities held for sale (Note 4) | $0 | $0 | — | — |
| Total liabilities | $30.0B | $29.9B | $30.0B | $30.0B |
| Common stock, par value $0.01 per share, 800,000,000 shares authorized, 51,678,269 and 52,089,008 shares issued and 49,382,180 and 49,792,919 shares outstanding at June 30, 2026 and December 31, 2025, respectively | $500000.00 | $500000.00 | $500000.00 | $500000.00 |
| Additional paid-in capital | $1.7B | $1.7B | $1.7B | $1.7B |
| Retained earnings | $5.1B | $4.9B | $4.7B | $4.6B |
| Accumulated other comprehensive loss | ($600.0M) | ($629.0M) | ($547.0M) | ($634.6M) |
| Treasury stock, at cost; 2,296,089 shares at June 30, 2026 and December 31, 2025 | -122.8M | -122.8M | -122.8M | -122.8M |
| Total stockholders’ equity | $6.1B | $5.9B | $5.8B | $5.5B |
| Total liabilities and stockholders’ equity | $36.1B | $35.8B | $35.8B | $35.5B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net income | $872.7M | $760.2M | $642.5M | $276.6M |
| Deferred tax expense (benefit) | $101.4M | $244.9M | ($108.5M) | $63.8M |
| Depreciation and amortization | $250.0M | $223.5M | $196.4M | $182.0M |
| Net realized losses on investments, including impairment losses | $71.8M | $75.8M | $68.7M | $179.7M |
| Loss (gain) on extinguishment of debt | $1.3M | $0 | ($100.0K) | $900.0K |
| Restructuring costs | $27.3M | $5.4M | $34.3M | $41.8M |
| Loss on sale of business | $10.7M | $8.6M | — | — |
| Stock based compensation expense | $85.7M | $81.1M | $75.1M | $62.6M |
| Insurance policy reserves and expenses | ($266.3M) | $1.2B | $9.4M | $1.9B |
| Premiums and accounts receivable | $95.7M | $172.8M | $120.6M | ($465.6M) |
| Commissions payable | $72.6M | $36.6M | ($92.6M) | ($30.7M) |
| Reinsurance recoverable | $627.6M | ($892.2M) | $345.6M | ($809.5M) |
| Funds withheld under reinsurance | ($12.7M) | ($112.6M) | $25.4M | $4.9M |
| Deferred acquisition costs and value of business acquired (Note 12 and 15) | ($136.5M) | ($26.8M) | ($81.9M) | ($552.2M) |
| Taxes receivable | ($4.2M) | ($116.5M) | ($92.9M) | $88.2M |
| Other assets and other liabilities | $11.6M | ($324.2M) | $95.9M | ($349.9M) |
| Other | $25.2M | ($65.8M) | ($31.3M) | ($22.5M) |
| Net cash provided by operating activities | $1.8B | $1.3B | $1.1B | $596.9M |
| Fixed maturity securities available for sale | $1.2B | $1.3B | $1.5B | $2.5B |
| Equity securities | $43.5M | $87.6M | $52.7M | $52.3M |
| Other invested assets | $60.9M | $91.6M | $90.7M | $144.7M |
| Subsidiary, net of cash transferred | $0 | ($5.0M) | $0 | $4.8M |
| Fixed maturity securities available for sale | $807.1M | $564.4M | $280.2M | $483.6M |
| Commercial mortgage loans on real estate | $71.8M | $40.6M | $20.4M | $40.5M |
| Fixed maturity securities available for sale | ($3.1B) | ($2.3B) | ($2.1B) | ($3.1B) |
| Equity securities | ($32.1M) | ($60.9M) | ($3.4M) | ($27.3M) |
| Commercial mortgage loans on real estate | ($56.0M) | ($57.2M) | ($55.6M) | ($80.3M) |
| Other invested assets | ($110.1M) | ($101.9M) | ($49.3M) | ($111.8M) |
| Property and equipment and other | ($235.5M) | ($221.3M) | ($202.5M) | ($186.3M) |
| Subsidiary, net of cash transferred | ($23.5M) | ($12.9M) | ($300.0K) | ($72.5M) |
| Change in short-term investments | ($95.7M) | ($27.0M) | ($90.8M) | $80.7M |
| Other | $6.0M | $100.0K | $2.4M | $600.0K |
| Net cash used in investing activities | ($1.5B) | ($657.8M) | ($637.7M) | ($262.1M) |
| Issuance of debt, net of issuance costs (Note 18) | $298.0M | $0 | $173.2M | — |
| Repayment of debt | ($176.3M) | $0 | ($225.0M) | — |
| Payment of contingent liability | $0 | $0 | ($2.5M) | — |
| Acquisition of common stock | ($303.7M) | ($307.4M) | ($193.1M) | ($572.8M) |
| Common stock dividends paid | ($168.4M) | ($155.9M) | ($152.3M) | ($150.2M) |
| Employee stock purchases and withholdings | ($13.8M) | ($14.2M) | ($4.2M) | ($19.5M) |
| Net cash used in financing activities | ($364.2M) | ($477.5M) | ($403.9M) | ($818.4M) |
| Effect of exchange rate changes on cash and cash equivalents | $14.5M | ($17.1M) | ($5.8M) | ($34.5M) |
| Change in cash and cash equivalents | $26.4M | $180.3M | $90.7M | ($518.1M) |
| Cash and cash equivalents at beginning of period - continuing operations | $1.8B | — | $1.6B | $1.5B |
| Cash and cash equivalents of continuing operations at end of period | $1.8B | — | — | — |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Net income | $572.7M | $274.1M | $647.5M | $381.9M |
| Deferred tax expense | $90.7M | $43.1M | $61.2M | $26.6M |
| Depreciation and amortization | $134.1M | $66.5M | $178.0M | $115.7M |
| Net realized losses on investments, including impairment losses | $31.4M | $21.2M | $51.3M | $37.7M |
| Loss on sale of business | $500.0K | $500.0K | — | — |
| Stock based compensation expense | $43.4M | $17.6M | $60.7M | $37.5M |
| Restructuring costs | $0 | $0 | ($1.4M) | ($1.4M) |
| Insurance policy reserves and expenses | $183.9M | $61.5M | ($442.9M) | ($394.3M) |
| Premiums and accounts receivable | ($2.9M) | ($16.7M) | $192.4M | $163.8M |
| Commissions payable | ($20.9M) | ($36.7M) | $26.1M | $26.4M |
| Reinsurance recoverable | $121.1M | ($71.1M) | $508.8M | $236.1M |
| Funds withheld under reinsurance | $16.7M | $21.2M | $700.0K | ($11.3M) |
| Deferred acquisition costs and value of business acquired | ($172.3M) | ($4.8M) | ($78.2M) | ($94.2M) |
| Taxes receivable | ($83.5M) | ($99.6M) | ($60.2M) | ($110.1M) |
| Other assets and other liabilities | ($199.1M) | ($26.5M) | ($28.5M) | $224.4M |
| Other | ($21.1M) | ($10.0M) | $46.1M | $19.1M |
| Net cash provided by operating activities | $694.7M | $240.3M | $1.2B | $657.9M |
| Fixed maturity securities available for sale | $966.6M | $344.1M | $892.2M | $650.2M |
| Equity securities | $30.3M | $15.5M | $32.9M | $24.9M |
| Other invested assets | $40.8M | $27.1M | $31.9M | $21.1M |
| Subsidiary, net of cash transferred | $1.4M | $1.4M | — | — |
| Fixed maturity securities available for sale | $401.6M | $183.0M | $630.6M | $424.2M |
| Commercial mortgage loans on real estate | $41.1M | $25.1M | $53.6M | $39.1M |
| Fixed maturity securities available for sale | ($1.8B) | ($809.9M) | ($2.3B) | ($1.7B) |
| Equity securities | ($19.5M) | ($8.6M) | ($26.7M) | ($16.4M) |
| Commercial mortgage loans on real estate | ($21.6M) | ($9.6M) | ($41.6M) | ($26.6M) |
| Other invested assets | ($71.3M) | ($39.0M) | ($78.3M) | ($52.8M) |
| Property and equipment and other | ($92.9M) | ($47.7M) | ($176.2M) | ($113.3M) |
| Subsidiaries, net of cash transferred | ($15.3M) | ($14.1M) | ($22.4M) | $0 |
| Change in short-term investments | $46.7M | $50.4M | ($61.4M) | ($32.2M) |
| Other | $200.0K | $0 | $5.8M | $200.0K |
| Net cash used in investing activities | ($506.4M) | ($282.3M) | ($1.1B) | ($784.5M) |
| Acquisition of common stock | ($201.8M) | ($124.2M) | ($209.4M) | ($127.6M) |
| Common stock dividends paid | ($91.9M) | ($44.0M) | ($124.2M) | ($83.6M) |
| Employee stock purchases and withholdings | ($32.2M) | ($34.4M) | ($16.1M) | ($11.8M) |
| Net cash used in financing activities | ($325.9M) | ($202.6M) | ($228.0M) | ($223.0M) |
| Effect of exchange rate changes on cash and cash equivalents | $2.2M | $2.2M | $23.9M | $28.6M |
| Change in cash and cash equivalents | ($135.4M) | ($242.4M) | ($95.2M) | ($321.0M) |
| Cash and cash equivalents at beginning of period | $1.8B | $1.8B | $1.8B | $1.8B |
| Cash and cash equivalents at end of period | $1.7B | $1.6B | $1.7B | $1.5B |
ASSURANT, INC. score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.